Take charge of CLTI.
Critical limb ischemia (CLI), now more commonly referred to as chronic limb-threatening ischemia (CLTI), is a growing health concern that significantly impacts patient quality of life and ability to function.
Optimize outcomes.
Our broad below-the-knee (BTK) portfolio and proven therapies offer the toolset you need to access, cross, and treat lesions with confidence.
Estimated 1.0–2.2 million people in the United States with CLI.1,2
Less than 1/3 of patients with CLI are prescribed optimal medical therapy.3
Up to 40% of untreated CLI patients are at risk of amputation at one year.4
Treat with confidence.
HawkOne™ Directional
Atherectomy System
Click, flush, go
Providing versatility, simplicity, and procedural efficiency† to restore blood flow in lesions above and below the knee.
- Versatility to remove plaque and restore flow
- Treat soft plaque to severe calcium
- No capital equipment for quick and easy setup
Risks may include but are not limited to: arterial perforation, embolism or arterial thrombosis, arterial dissection, arterial spasm, and vascular complications that could require surgical repair.
Chocolate™* PTA Balloon Catheter
A unique nitinol cage encases the Chocolate PTA balloon for controlled dilatation.
- Confidently size 1:1
- The pillows apply the force required for effective dilatation. The grooves relieve stress to minimize flow-limiting dissections.5
Risks may include: abrupt or subacute closure, pseudo-aneurysm, thrombosis, allergic reaction to device materials or procedural medications, arterial injury (such as dissection, perforation, or rupture), embolism, hematoma, and hemorrhage.
Contact us.
Connect with a Medtronic representative to receive updates and information on our products and therapies.
*
™Third-party brands are trademarks of their respective owners.
†
Compared to TurboHawk™ directional atherectomy.
References
1
Goodney PP, Travis LL, Nallamothu BK, et al. Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes. January 2012;5(1);94-102.
2
Yost M. Critical Limb Ischemia Volume I, United States Epidemiology, Supplement 2016. Atlanta, GA: The Sage Group; 2016.
3
Chung J, Timaran DA, Modrall JG, et al. Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia. J Vasc Surg. October 2013;58(4):972-980.
4
Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. October 19, 2013;382(9901):1329-1340.
5
Medtronic data on file. Final Study Report The Chocolate BAR CLR782.